EllumGet notified

What is Eloralintide?

The short answer

Eloralintide is a peptide, a short chain of amino acids.

  • What it is

    Eloralintide: Amylin receptor agonist (peptide).

  • What people look into

    Weight

By Ellum EditorialUpdated AI use

Get updates on Eloralintide

What it is

Also known as
eloralintide peptide, ly3841136

Regulatory status

Investigational (phase 3) How we label status

As of October 7, 2026, Eloralintide is not FDA-approved for any use and is not on FDA's 503A bulks list. It is in phase 3 trials.

See Eloralintide in the Index →

Federal (FDA)
Investigational, phase 3 (Eli Lilly); no FDA approval record
503A compounding
No category; not on 216.23 as of 2026-10-07; not an approved-drug component (as of October 7, 2026)

References

Sources as of October 7, 2026

  1. ClinicalTrials.gov: clinicaltrials.gov/study/NCT07282600
  2. ClinicalTrials.gov: clinicaltrials.gov/study/NCT07321886
  3. FDA: api.fda.gov/drug/drugsfda.json
  4. FDA: www.fda.gov/media/94155/download
  5. eCFR: www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-216/subpart-B/section-216.23